Intraperitoneal ondansetron hydrochloride for intractable nausea and vomiting due to diabetic gastroparesis in a patient on peritoneal dialysis.
D000328:Adult; D000932:Antiemetics / Q000008:administration & dosage* / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D005260:Female; D018589:Gastroparesis / Q000150:complications*; D006801:Humans; D007263:Infusions, Parenteral; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D009325:Nausea / Q000188:drug therapy* / Q000209:etiology*; D017294:Ondansetron / Q000008:administration & dosage* / Q000627:therapeutic use*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D014839:Vomiting / Q000188:drug therapy* / Q000209:etiology*
D000932:Antiemetics; D017294:Ondansetron